Related Experiment Video

Updated: Oct 10, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

HIV-related nontuberculous mycobacterial infection: incidence, survival analysis and associated risk factors

K N Arastéh1, C Cordes, M Ewers

  • 1Auguste-Viktoria Krankenhaus, Rubensstr. 125, D-12157 Berlin, Germany. arasteh@avk.b.shuttle.de

European Journal of Medical Research
|November 15, 2000
PubMed

Insights

Nontuberculous mycobacterial (NTM) infections are common in AIDS patients, with incidence increasing over time. However, NTM infection did not impact survival rates in these patients.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Nontuberculous mycobacterial (NTM) infections pose a significant health challenge for individuals with Acquired Immunodeficiency Syndrome (AIDS).
  • Understanding the incidence and prognostic factors of NTM infections in AIDS patients is crucial for clinical management and public health strategies.

Purpose of the Study:

  • To determine the incidence rates of NTM infections in hospitalized AIDS patients.
  • To analyze survival times in AIDS patients with and without NTM infections.
  • To identify risk factors associated with NTM disease and dissemination in the context of AIDS.

Main Methods:

  • Retrospective study analyzing data from 1540 hospitalized AIDS patients.
  • Evaluation of incidence rates of NTM infections per 100 person-years (PY).
  • Statistical analysis to identify factors influencing NTM disease and dissemination, and their impact on survival.

Main Results:

  • Overall NTM incidence was 16.6/100 PY, increasing from 12.1/100 PY (1987-1990) to 18.9/100 PY (1991-1994).
  • Antiretroviral therapy (ART) and toxoplasmosis prophylaxis decreased NTM risk; CD4 cells <40/microliter increased risk 2.5-fold.
  • Pneumocystis carinii pneumonia (PCP), wasting syndrome, and PCP prophylaxis increased progression from colonization to dissemination; Cryptococcus neoformans infection was linked to immediate NTM dissemination.

Conclusions:

  • Despite an increased incidence of NTM dissemination, survival rates did not differ between AIDS patients with and without NTM infection.
  • Early AIDS-defining illnesses with low CD4 counts and specific opportunistic infections are significant risk factors for NTM disease and dissemination.
  • ART and prophylaxis play a role in mitigating NTM risk, highlighting the importance of comprehensive care for AIDS patients.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...